Trial With Gemcitabine and Rapamycin in Second Line of Metastatic Osteosarcoma
Clinical trial NCT02429973 · COMPLETED
Trial details
- NCT number
- NCT02429973
- Sponsor
- Broto, Javier Martín, M.D.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2014-12-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.